Cardioprotective and Lipid Lowering Effects of Shatavari

Cardiovascular diseases (CVDs) are the most prominent causes of global mortality, prompting the exploration of effective and safe therapeutic strategies. A popular medicinal herb, Asparagus racemosus , also known as Shatavari in Ayurvedic tradition, is recognized for its adaptogenic and rejuvenating properties. This chapter focuses on the cardioprotective potential of A. racemosus , consolidating findings from preclinical and limited clinical studies. The plant contains diverse phytochemicals, including saponins (notably shatavarins), flavonoids, and alkaloids, which contribute to its antioxidant, anti-inflammatory, and lipid-lowering effects. Experimental studies indicate that Shatavari may protect myocardial tissue by enhancing endogenous antioxidant defense mechanisms, improving lipid profiles, and attenuating myocardial damage during ischemia-reperfusion injury. The presence of phytosterols and saponins is particularly significant in inhibiting cholesterol synthesis and promoting lipid excretion. Its role in modulating oxidative stress and inflammation further reinforces its cardioprotective efficacy. Despite promising findings, current evidence is largely preclinical, with a lack of well-designed human clinical trials. Pre-treatment with Shatavari extract demonstrated a dose-dependent protective effect by significantly restoring biochemical markers and improving cardiac histopathology. Standardization of extracts, detailed pharmacodynamic studies, and safety evaluations remain essential to establish A. racemosus as a viable cardioprotective agent. This chapter supports further in-depth research to validate its therapeutic potential and pave the way for its integration into evidence-based cardioprotective regimens.